To Top

Anxiety, sleeping pills don’t put you at increased dementia risk

Shivani Choudhary, 7, a street performer sleeps on her hut at the slum on the bank of Manahara River after a whole day of street performance in Kathmandu August 15, 2012. Shivani and her brothers Drumpal and Gchan, who came to Kathmandu from India 5 years ago, earn their living by performing tricks on the streets of Kathmandu. According to Drumpal, Shivani's older brother, they earn around $10 a day by performing tricks, which is not enough to feed their 10-member family living together in a small hut without a proper toilet or any basic needs.  REUTERS/Navesh Chitrakar (NEPAL - Tags: SOCIETY POVERTY IMMIGRATION)

Washington D.C, Feb-3 News: A new study has suggested that taking drugs for anxiety and sleep problems is not associated with an increased dementia.

These results from the University of Washington (UW) and Group Health in Seattle do not support a direct (causal) association between benzodiazepine (widely used drugs to treat anxiety and insomnia) use and dementia, say the researchers.

However, the researchers suggest that healthcare providers should avoid benzodiazepines in older adults to prevent important adverse health outcomes.

Benzodiazepines are widely prescribed among older adults to manage sleep, anxiety and depressive disorders. Some studies have suggested that benzodiazepine use could be associated with an increased risk of dementia, but results are conflicting.

The study involved 3,434 participants at Group Health aged 65 and older without dementia at study entry, who were followed for an average of seven years.

During follow-up, 797 participants developed dementia, of whom 637 developed Alzheimer’s disease.

The team found no association between the highest level of benzodiazepine use (the median level of use in this group was equivalent to about one year of daily use) and dementia or cognitive decline.

Contrary to expectations, they found a small increased risk for dementia in people with low (up to one month) or moderate (one to four months) use.

The study appears in The BMJ.

Source: ANI News

Leave a Reply

Your email address will not be published. Required fields are marked *

More in Health

Copyright © 2016 Today9 News. | Design and Developed by BrandShow Digital Solutions